Lu Wang

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin‐Yuan Shih et al. · Proceedings of the National Academy of Sciences · 2007 · 1.6K citations

Harbors Met Amplification, Engineering, Pathology +18

High-throughput genotyping by whole-genome resequencing

Xuehui Huang, Qi Feng, Qian Qian et al. · Genome Research · 2009 · 957 citations · Full text

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Matthew J. Bott, Marie Brevet, Barry S. Taylor et al. · Nature Genetics · 2011 · 723 citations

Tumor Biology, Malignant Pleural Mesothelioma, Somatic Mutations +7

Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling

Juliann Chmielecki, Jasmine Foo, Geoffrey R. Oxnard et al. · Science Translational Medicine · 2011 · 524 citations

Response to Cabozantinib in Patients with <i>RET</i> Fusion-Positive Lung Adenocarcinomas

Alexander Drilon, Lu Wang, Adnan Hasanovic et al. · Cancer Discovery · 2013 · 470 citations · Full text